Skip to main navigation Skip to search Skip to main content

Clinical Management of Wound Healing and Hypertrophic Scarring

Research output: Chapter in Book/Report/Conference proceedingChapter

Abstract

In health, wound healing in adult humans results in the deposition of fibrotic tissue, known as scar. This process is similar throughout the body, and when it occurs in tissues such as the heart, lung, or liver, it can result in end-organ dysfunction. When normal homeostatic mechanisms fail and dysfunctional wound healing prevails, the result can range from nonhealing ulcers requiring amputation to large debilitating scars. This chapter provides an overview of the cellular and molecular processes underlying cutaneous wound healing. Mechanisms involved in dysfunctional wound healing are highlighted, ranging from nonhealing ulcers to fibroproliferative disease. Current therapies for dysfunctional healing are discussed, with an emphasis on emerging therapeutic concepts and opportunities for further research.

Original languageEnglish (US)
Title of host publicationSkin Tissue Engineering and Regenerative Medicine
PublisherElsevier Inc.
Pages61-81
Number of pages21
ISBN (Print)9780128016541
DOIs
StatePublished - 2016
Externally publishedYes

Keywords

  • Fibroproliferative disease
  • Fibrosis
  • Hypertrophic
  • Keloid
  • Regeneration
  • Scar reduction
  • Scarless
  • Stem cells
  • Tissue engineering
  • Wound healing

ASJC Scopus subject areas

  • General Engineering
  • General Biochemistry, Genetics and Molecular Biology

Fingerprint

Dive into the research topics of 'Clinical Management of Wound Healing and Hypertrophic Scarring'. Together they form a unique fingerprint.

Cite this